Cefzil For Oral Suspension (cefprozil) 250 MG/5 ML Trademark Details

Cefzil for Oral Suspension (Cefprozil) 250 Mg/5 Ml was registered on Tuesday, May 28, 2002 and is currently owned by Bristol-Myers Squibb Company under the registration number 2573175 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 11 years ago on Friday, January 4, 2013, according to the United State Patent & Trademark Office
Word Mark Cefzil for Oral Suspension (Cefprozil) 250 Mg/5 Ml
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 76150137
Registration Number 2573175
Status Date Friday, January 4, 2013
Filing Date Friday, January 4, 2013
Registration Date Tuesday, May 28, 2002
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Disclaimer with Predetermined Text "ORAL SUSPENSION", "CEFROZIL" and "250 MG/ 5 ML"
Goods & Services Antibiotic Pharmaceutical Preparation

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, January 4, 2013
First Use Anywhere Friday, September 15, 2000
First Use In Commerce Friday, September 15, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.